학술논문
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
Document Type
Article
Author
Source
In Parkinsonism and Related Disorders April 2019 61:88-93
Subject
Language
ISSN
1353-8020